JULIE MONK

Joining RAGE Biotech in 2024, Dr Julie Monk supports RAGE's clinical, regulatory, and business development strategies. Julie brings 20+ years’ experience to the team having worked as a medical writer across the drug development pipeline at CSL Limited, Paradigm Biopharmaceuticals, Envision Pharma Group (formerly ProScribe), and as a clinical development coordinator at Monash University.

Julie holds a PhD in Biochemistry and Molecular Biology and a Bachelor of Arts (Cinema Studies) / Bachelor Of Science (Biochemistry and Molecular Biology, and Genetics) from the University of Melbourne.